Status | Study |
Completed |
Study Name: Adult Subjects Suffering From Lower Limb Spasticity Following Stroke Condition: Spasticity Date: 2011-09-27 |
Completed |
Study Name: Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity Condition: Muscle Spasticity Date: 2011-06-30 Interventions: Biological: botulinum toxin Type A Botulinum toxin Type A treatment at a dose determined by the physicia |
Completed |
Study Name: Retrospective Study of Patients With Spasticity in the Spanish Population Condition: Muscle Spasticity Date: 2011-06-27 Interventions: Other: No treatment There was no treatment in this study. |
Completed |
Study Name: MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity Condition: Spasticity Date: 2011-03-10 Interventions: Drug: Botulinum toxin type A B |
Completed |
Study Name: Effect of Cannabinoids on Spasticity and Neuropathic Pain in Spinal Cord Injured Persons Condition: Muscle Spasticity as a Result of Spinal Cord Injury Date: 2010-10-14 Interventions: Drug: nabilone 0.5 mg nabilone |
Completed |
Study Name: SISTERS: Spasticity In Stroke Study - Randomized Study Condition: Severe Spasticity Date: 2009-12-07 Interventions: Drug: intrathecal baclofen ITB test, implant, 6 months follow-up |
Completed |
Study Name: To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke Condition: Muscle Spasticity Date: 2009-11-24 |
Completed |
Study Name: Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity Condition: Spasticity Date: 2009-01-07 Interventions: Drug: Botulinum toxin type A from laboratory Lanzhou |
Completed |
Study Name: A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury Condition: Muscle Spasticity Date: 2007-11-12 Interventions: Drug: XP19986 SR1, 10 mg BID X |
Completed |
Study Name: BOTOX® Economic Spasticity Trial (BEST) Condition: Muscle Spasticity Date: 2007-10-24 Interventions: Biological: Botulinum Toxin Type A 900kD |